Back
Day Range
$86.64
$88.72
52-Week Range
$81.36
$118.30
Volume
664,878
50D / 200D Avg
$100.54
/
$95.51
Prev Close
$85.94
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 40.3 | 0.4 |
| P/B | 1.3 | 2.9 |
| ROE % | 3.2 | 3.8 |
| Net Margin % | 8.5 | 3.9 |
| Rev Growth 5Y % | -7.1 | 10.0 |
| D/E | 0.5 | 0.2 |
Key Takeaways
Revenue declined -7.06% annually over 5 years
Earnings declined -18.31% over the past year
ROE of 3.24% is below average
Debt/Equity of 0.48 — conservative balance sheet
Generating 508.26M in free cash flow
P/E of 40.32 — premium valuation
Growth
Revenue Growth (5Y)
-7.06%
Revenue (1Y)3.67%
Earnings (1Y)-18.31%
FCF Growth (3Y)616.37%
Quality
Return on Equity
3.24%
ROIC2.48%
Net Margin8.46%
Op. Margin12.49%
Safety
Debt / Equity
0.48
Current Ratio1.68
Interest Coverage3.87
Valuation
P/E Ratio
40.32
P/B Ratio1.34
EV/EBITDA34.60
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 3.67% | Revenue Growth (3Y) | 1.90% |
| Earnings Growth (1Y) | -18.31% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -7.06% | Earnings Growth (5Y) | -28.85% |
| Profitability | |||
| Revenue (TTM) | 2.86B | Net Income (TTM) | 241.68M |
| ROE | 3.24% | ROA | 1.99% |
| Gross Margin | 53.08% | Operating Margin | 12.49% |
| Net Margin | 8.46% | Free Cash Flow (TTM) | 508.26M |
| ROIC | 2.48% | FCF Growth (3Y) | 616.37% |
| Safety | |||
| Debt / Equity | 0.48 | Current Ratio | 1.68 |
| Interest Coverage | 3.87 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 40.32 | P/B Ratio | 1.34 |
| P/S Ratio | 3.41 | PEG Ratio | -3.32 |
| EV/EBITDA | 34.60 | Dividend Yield | 0.00% |
| Market Cap | 9.74B | Enterprise Value | 12.34B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 2.86B | 2.76B | 2.75B | 3.31B | 3.83B |
| Net Income | 241.68M | 295.83M | -118.38M | 569.18M | 943.16M |
| EPS (Diluted) | 2.08 | 2.41 | -0.95 | 4.50 | 8.08 |
| Gross Profit | 1.52B | 1.32B | 1.32B | 1.76B | 2.28B |
| Operating Income | 356.64M | 410.52M | 399.49M | 781.12M | 1.34B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 12.17B | 12.39B | 13.56B | 14.13B | 15.00B |
| Total Liabilities | 4.92B | 4.73B | 5.69B | 6.75B | 7.86B |
| Shareholders' Equity | 7.25B | 7.67B | 7.87B | 7.38B | 7.14B |
| Total Debt | 3.52B | 3.33B | 4.07B | 4.60B | 5.16B |
| Cash & Equivalents | 919.87M | 1.16B | 913.16M | 454.36M | 603.32M |
| Current Assets | 2.24B | 2.35B | 3.00B | 3.29B | 2.44B |
| Current Liabilities | 1.33B | 653.10M | 1.45B | 1.54B | 1.21B |